Leukemia Stem Cells Are Characterized By CLEC12A Expression and Chemotherapy Refractoriness That Can be Overcome By Targeting with Chimeric Antigen Receptor T Cells

被引：17
|
作者：
Kenderian, Saad S.
Ruella, Marco
Shestova, Olga
Klichinsky, Michael
Kim, Miriam Y.
Soderquist, Craig
Bagg, Adam
Singh, Reshma
Richardson, Celeste
Young, Regina M.
June, Carl H.
Gill, Saar I.
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.766.766
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
766
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Targeting CLEC12A with Chimeric Antigen Receptor T Cells Can Overcome the Chemotherapy Refractoriness of Leukemia Stem Cells
    Kenderian, Saad S.
    Ruella, Marco
    Shestova, Olga
    Klichinsky, Michael
    Kim, Miriam
    Soderquist, Craig
    Bagg, Adam
    Singh, Reshma
    Richardson, Celeste
    Young, Regina
    June, Carl H.
    Gill, Saar I.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S206 - S207
  • [2] Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
    Alhabbab, Rowa Y.
    FRONTIERS IN GENETICS, 2020, 11
  • [3] Blast cells in acute megakaryoblastic leukaemia with Down syndrome are characterized by low CLEC12A expression
    Matsuo, Hidemasa
    Wakita, Tomohiro
    Hiramatsu, Hidefumi
    Ohmori, Katsuyuki
    Kodama, Kumi
    Nakatani, Kana
    Kamikubo, Yasuhiko
    Iwamoto, Shotaro
    Kondo, Tadakazu
    Takaori-Kondo, Akifumi
    Takita, Junko
    Tomizawa, Daisuke
    Taga, Takashi
    Adachi, Souichi
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (01) : E7 - +
  • [4] Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia
    Le, Quy
    Castro, Sommer
    Tang, Thao
    Loeb, Anisha M.
    Hylkema, Tiffany
    McKay, Cyd Nourigat
    Perkins, LaKeisha
    Srivastava, Shivani
    Call, Lindsey
    Smith, Jenny
    Leonti, Amanda
    Ries, Rhonda
    Pardo, Laura
    Loken, Michael R.
    Correnti, Colin
    Fiorenza, Salvatore
    Turtle, Cameron J.
    Riddell, Stanley
    Tarlock, Katherine
    Meshinchi, Soheil
    CLINICAL CANCER RESEARCH, 2021, 27 (20) : 5718 - 5730
  • [5] Chimeric antigen receptor T cells get passed by leukemia
    Locke, Frederick L.
    Davila, Marco L.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S315 - S317
  • [6] TREATMENT OF ADVANCED LEUKEMIA WITH CHIMERIC ANTIGEN RECEPTOR T CELLS
    不详
    CANCER DISCOVERY, 2011, 1 (04) : 282 - 282
  • [7] Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia
    Cummins, Katherine
    Gill, Saar
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1125 - 1147
  • [8] Chimeric antigen receptor T cells for acute myeloid leukemia
    Fetsch, Viktor
    Zeiser, Robert
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (01) : 28 - 35
  • [9] Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
    Maude, Shannon L.
    Frey, Noelle
    Shaw, Pamela A.
    Aplenc, Richard
    Barrett, David M.
    Bunin, Nancy J.
    Chew, Anne
    Gonzalez, Vanessa E.
    Zheng, Zhaohui
    Lacey, Simon F.
    Mahnke, Yolanda D.
    Melenhorst, Jan J.
    Rheingold, Susan R.
    Shen, Angela
    Teachey, David T.
    Levine, Bruce L.
    June, Carl H.
    Porter, David L.
    Grupp, Stephan A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (16): : 1507 - 1517
  • [10] Chimeric antigen receptor T cells for acute lymphoblastic leukemia
    Frey, Noelle V.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S24 - S27
12345